欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	ES/H/1010/001
药品名称	Docetaxel AqVida 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung
活性成分	Docetaxel 20.0 mg/ml
剂型	Concentrate for solution for infusion
上市许可持有人	AqVida GmbH Kaiser-Wilhelm-Straße 89 D-20355 Hamburg Germany
参考成员国 - 产品名称	Spain (ES)
互认成员国 - 产品名称	Greece (GR)
许可日期	2014/02/27
最近更新日期	2025/09/11
药物ATC编码	L01CD02 docetaxel
申请类型	TypeLevel1：[not specified] TypeLevel2：[not specified] TypeLevel3：[not specified] TypeLevel4：[not specified] TypeLevel5：[not specified]
附件文件下载	PubAR \| 04_DE_3508_3509_3863_1_DC_Doxetacel_final PARDate of last change:2024/09/06 Final Product Information \| common_final_pl_3508_V012Date of last change:2024/09/06 Final Product Information \| common_final_smpc_3508_V012Date of last change:2024/09/06 Final Labelling \| m1_3_1_common_labip_DE_H_3508_001_DC_clear_2014_02_13Date of last change:2024/09/06 Final Labelling \| m1_3_1_common_labip_DE_H_3509_001_DC_clear_2014_02_25Date of last change:2024/09/06 Final Labelling \| m1_3_1_common_labip_DE_H_3863_001_clear_2014_02_13Date of last change:2024/09/06 Final Labelling \| m1_3_1_common_labop_DE_H_3508_001_DC_clear_2013_12_30Date of last change:2024/09/06 Final Labelling \| m1_3_1_common_labop_DE_H_3509_001_DC_clear_2014_02_25Date of last change:2024/09/06 Final Labelling \| m1_3_1_common_labop_DE_H_3863_001_DC_clear_2013_12_30Date of last change:2024/09/06 Final PL \| m1_3_1_common_pil_DE_H_3508_001_DC_clear_2014_02_24Date of last change:2024/09/06 Final PL \| m1_3_1_common_pil_DE_H_3509_001_DC_clear_2014_02_25Date of last change:2024/09/06 Final PL \| m1_3_1_common_pil_DE_H_3863_001_clear_2014_02_24Date of last change:2024/09/06 Final SPC \| m1_3_1_common_smpc_DE_H_3508_001_DC_clear_2014_02_18Date of last change:2024/09/06 Final SPC \| m1_3_1_common_smpc_DE_H_3509_001_DC_clear_2014_02_25Date of last change:2024/09/06 Final SPC \| m1_3_1_common_smpc_DE_H_3863_001_DC_clear_2014_02_18Date of last change:2024/09/06
市场状态	Positive